Overview

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

A study to compare a conivaptan PK in subjects with mild or moderate kidney function impairment to subjects with normal kidney function after a 48-hour continuous infusion of conivaptan.

Phase:

Phase 1

Details

Lead Sponsor:

Cumberland Pharmaceuticals

Treatments:

Conivaptan